October 22nd 2025, 8:00pm
After being diagnosed with stage 3 triple-negative breast cancer at 29, Meagan Pettit urges young adults to seek community and define life beyond diagnosis.
October 22nd 2025, 7:00pm
Fran Curtis is a survivor of breast, appendix and skin cancer, but said bladder cancer was the toughest.
October 22nd 2025, 5:00pm
The story of prevention doesn't end with a surgery date or a clean scan — it unfolds over decades, shaped by habits, choices and vigilance.
October 22nd 2025, 4:00pm
In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.
October 22nd 2025, 3:13pm
The FDA accepted an application for Padcev plus Keytruda for patients with muscle-invasive bladder cancer ineligible for cisplatin-containing chemotherapy.
October 22nd 2025, 1:00pm
Experts discuss how better hospice and home care reimbursement can help patients receive compassionate end-of-life care at home.
October 21st 2025, 9:00pm
Get the facts on stage 1 multiple myeloma, including why your doctor may recommend active surveillance and what the latest treatment options are.
October 21st 2025, 8:00pm
The addition of postsurgical Verzenio to endocrine therapy provided a benefit in HR–positive, HER2-negative breast cancer.
October 21st 2025, 7:00pm
Learn what stage 2 ovarian cancer means, how it’s diagnosed, treatment options like surgery and chemotherapy, and key questions to ask your oncologist.
October 21st 2025, 5:00pm
Shopping for prostheses reminded me of being in a very popular old toy store.
FDA Grants Orphan Drug Designation to DPTX3186 Therapy in Gastric Cancer
Inlexzo Offers New Option for Patients With Unresponsive Bladder Cancer
Managing Lynch Syndrome
New Directions in Treatment for Patients With GIST